GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » 3B BlackBio Dx Ltd (BOM:532067) » Definitions » EV-to-EBITDA

3B BlackBio Dx (BOM:532067) EV-to-EBITDA : 15.65 (As of May. 17, 2024)


View and export this data going back to 1996. Start your Free Trial

What is 3B BlackBio Dx EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, 3B BlackBio Dx's enterprise value is ₹6,267.2 Mil. 3B BlackBio Dx's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was ₹400.6 Mil. Therefore, 3B BlackBio Dx's EV-to-EBITDA for today is 15.65.

The historical rank and industry rank for 3B BlackBio Dx's EV-to-EBITDA or its related term are showing as below:

BOM:532067' s EV-to-EBITDA Range Over the Past 10 Years
Min: 1.12   Med: 7.78   Max: 19.55
Current: 15.65

During the past 13 years, the highest EV-to-EBITDA of 3B BlackBio Dx was 19.55. The lowest was 1.12. And the median was 7.78.

BOM:532067's EV-to-EBITDA is ranked worse than
60.57% of 459 companies
in the Biotechnology industry
Industry Median: 10.28 vs BOM:532067: 15.65

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-17), 3B BlackBio Dx's stock price is ₹798.35. 3B BlackBio Dx's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was ₹38.779. Therefore, 3B BlackBio Dx's PE Ratio for today is 20.59.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


3B BlackBio Dx EV-to-EBITDA Historical Data

The historical data trend for 3B BlackBio Dx's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

3B BlackBio Dx EV-to-EBITDA Chart

3B BlackBio Dx Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
EV-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only 6.48 4.66 1.30 5.69 7.71

3B BlackBio Dx Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 9.84 7.71 8.05 13.79 16.92

Competitive Comparison of 3B BlackBio Dx's EV-to-EBITDA

For the Biotechnology subindustry, 3B BlackBio Dx's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


3B BlackBio Dx's EV-to-EBITDA Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, 3B BlackBio Dx's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where 3B BlackBio Dx's EV-to-EBITDA falls into.



3B BlackBio Dx EV-to-EBITDA Calculation

3B BlackBio Dx's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=6267.174/400.55
=15.65

3B BlackBio Dx's current Enterprise Value is ₹6,267.2 Mil.
3B BlackBio Dx's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹400.6 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


3B BlackBio Dx  (BOM:532067) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

3B BlackBio Dx's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=798.35/38.779
=20.59

3B BlackBio Dx's share price for today is ₹798.35.
3B BlackBio Dx's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹38.779.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


3B BlackBio Dx EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of 3B BlackBio Dx's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


3B BlackBio Dx (BOM:532067) Business Description

Traded in Other Exchanges
N/A
Address
7-C, Industrial Area, Govindpura, Bhopal, MP, IND, 462023
3B BlackBio Dx Ltd is one of the leading Indian companies in the field of PCR-based Molecular Diagnostic Kits. The Company is ISO 13485:2016 certified, GMP-compliant biotech R&D organization, as an Indo-Spanish JV company and engaged in the design, development, manufacturing and commercialization of PCR based Molecular Diagnostic kits, PCR Enzymes & PCR Reagents.

3B BlackBio Dx (BOM:532067) Headlines

No Headlines